- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Comparing Apples to Broccoli
Pharmaceutical Executive
In late March, the Supreme Court debated the merits-or lack thereof-of the Obama Administration's Patient Protection and Affordable Care Act. Can you match the analogy with the Justice?
In late March, the Supreme Court debated the merits—or lack thereof—of the Obama Administration's Patient Protection and Affordable Care Act (ACA). The law's key provision, the individual mandate, sparked a proliferation of analogies from the Justices. Some of the analogies were helpful, some less so, but each one provided an insight into that particular Justice's thinking on the issue. Can you match the analogy with the Justice? (Hint: Two are from Justice Scalia)
Photo: Chip Somodevilla/Getty Images
Answers: A: Justice Scalia. B: Justice Breyer. C: Justice Sotomayor. D: Chief Justice Roberts. E: Justice Scalia.
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
Efsitora Demonstrates Non-Inferiority vs. Insulin Glargine, Degludec for Type 2 Diabetes
September 5th 2024Results from the QWINT-1 and QWINT-3 trials found that insulin-naïve patients achieved similar reductions in A1C levels using once-weekly efsitora compared to daily insulin glargine and degludec.
